810223P
Avanti
C12-NBD Glucosyl Ceramide
Avanti Polar Lipids 810223P, powder
Synonym(s):
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-β1-1′-sphingosine
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 250 μg (810223P-250ug)
manufacturer/tradename
Avanti Polar Lipids 810223P
shipped in
dry ice
storage temp.
−20°C
Application
C12-NBD Glucosyl Ceramide is suitable for liposome preparation.
Biochem/physiol Actions
Glucosyl ceramide (GlcCer) is produced by GlcCer synthase from ceramide in the cytosolic membranes of Golgi. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids.
Packaging
5 mL Amber Glass Screw Cap Vial (810223P-250ug)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
The effects of chemically synthesized saposin C on glucosylceramide-beta-glucosidase
Clinical Biochemistry, 48(16-17), 1177-1180 (2015)
Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide
Nature, 449(7158), 62-62 (2007)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service